Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
FDA May Authorize Pfizer-BioNTech's COVID-19 Booster For 5-11 Year Kids Soon: NYT
The FDA is expected to authorize a booster shot ofPfizer Inc(NYSE:PFE)/BioNTech SE's(NASDAQ:BNTX) COVID-19 vaccine for children ages 5 to 11, likely Tuesday, the New York Times reported, citing people familiar with the matter.
It is unclear how much demand there is for the third dose in the age group. According to the U.S. Centers for Disease Control and Prevention, just 28.8% of children ages...
Login or create a forever free account to read this news
Sign up/Log in